(Q85572797)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23196026%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

title

Clinical significance of hyperforin for the efficacy of Hypericum extracts on depressive disorders of different severities (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23196026%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

1 reference

G Laakmann

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23196026%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

A Dienel

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23196026%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

M Kieser

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23196026%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23196026%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23196026%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23196026%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23196026%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

435-442

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23196026%20AND%20SRC:MED&resulttype=core&format=json

Evaluation of experiments with adaptive interim analyses.

19 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

7 January 2021

Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

7 January 2021

Hyperforin as a possible antidepressant component of hypericum extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

7 January 2021

Antidepressant activity of hypericum perforatum and hyperforin: the neglected possibility

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

7 January 2021

Hyperforin, possibly the major non-nitrogenous secondary metabolite of Hypericum perforatum L

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

7 January 2021

St. John's Wort, an anti-depressant? A systematic, criteria-based review

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

7 January 2021

A rating scale for depression

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

7 January 2021

Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: a multicenter double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

7 January 2021

Mood disorders in the general population represent an important and worldwide public health problem

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

7 January 2021

St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

7 January 2021

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

7 January 2021

Adhyperforin: A Homologue of Hyperforin from Hypericum perforatum

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

1 reference

7 January 2021

Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

7 January 2021

Biologically active and other chemical constituents of the herb of Hypericum perforatum L.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

7 January 2021

Inhibition of monoamine oxidase by hypericin.

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

7 January 2021

Controlled clinical trials of hypericum extracts in depressed patients--an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

7 January 2021

Pharmaceutical quality of hypericum extracts

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

7 January 2021

LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0944-7113%2898%2980039-1

7 January 2021

Pharmaceutical Quality of Hypericum Extracts

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1177/089198879400701S18

Identifiers

DOI

10.1016/S0944-7113(98)80039-1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23196026%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference